The new platform services subscription contract with a top six U.S. pharma client marks a pivotal shift in Dario's pharma channel,…
NEW YORK, Nov. 4, 2024 /PRNewswire/ - Bio-K Plus, a Kerry Company and pioneer in the probiotic sector, is thrilled…
NEWTOWN, Pa., Nov. 4, 2024 /PRNewswire/ -- Catalyx, a global leader in machine vision and automation for highly regulated industries,…
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studiesCollaboration underscores Lonza's commitment to…
NEW YORK, Nov. 4, 2024 /PRNewswire/ -- Arsenal Capital Partners ("Arsenal"), a leading private equity firm specializing in building technology-rich,…
The cloud-based platform enhances FibroScan® capabilities, providing advanced tools for data-driven liver disease management PARIS, Nov. 4, 2024 /PRNewswire/ -- Liver…
SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company…
Segment featuring leading Neuro-Oncologist and Glioblastoma Key Opinion Leader, Professor Michael WellerAccess the segment here HOUSTON, TX / ACCESSWIRE /…
Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of…
Experienced CFO and investment banker with 30-year track record will help drive CureVac's transformationTÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE…